As the United Nations gears up for a high-level meeting on combating a global tuberculosis epidemic, Doctors Without Borders is urging Johnson & Johnson (JNJ) to widen access for a medicine that the advocacy group maintained is too costly for many countries.
In a Sept. 17 letter to the company, Doctors Without Borders argued that an “affordable and sustainable” supply of Sirturo is increasingly needed, especially after the World Health Organization recently recommended the drug as the backbone for treating multi-drug resistant tuberculosis.
Ouch. CEOs. Those cutbacks in copyediting are beginning to show. ;>
Every entrance to a J&J building has a big copy of their vaunted Credo hanging on the wall, and their CEO’s rarely miss an opportunity to humblebrag about it. But when it comes down to it…
Yes, the credo plaque in New Brunswick is a good reference point for many discussion.
ed at pharmalot
Comments are closed.